Alpha DNA Investment Management’s iShares MSCI EAFE Value ETF EFV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,922
Closed -$287K 177
2023
Q1
$287K Buy
+5,922
New +$287K 0.08% 140
2022
Q2
Sell
-4,124
Closed -$207K 132
2022
Q1
$207K Buy
+4,124
New +$210K 0.15% 114
2021
Q2
Sell
-3,218
Closed -$164K 260
2021
Q1
$164K Buy
+3,218
New +$160K 0.19% 104

Other funds holding EFV

Alpha DNA Investment Management's EFV Position: Q2 2023 in Review

Alpha DNA Investment Management sold out of iShares MSCI EAFE Value ETF (EFV) in Q2 2023, closing a stake of 5,922 shares — an estimated $287K sold.

Alpha DNA Investment Management first reported a position in EFV in Q1 2021 and held it in 3 quarters. The position peaked at $287K in Q1 2023. 809 funds tracked by Wall St. Rank hold EFV as of Q2 2023.

  • Alpha DNA Investment Management reported no remaining iShares MSCI EAFE Value ETF position as of Q2 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 5,922 iShares MSCI EAFE Value ETF shares in Q2 2023, an estimated $287K.
  • Alpha DNA Investment Management first reported a position in iShares MSCI EAFE Value ETF in Q1 2021 and held it in 3 quarters.
  • Alpha DNA Investment Management's iShares MSCI EAFE Value ETF position peaked at $287K in Q1 2023.
  • 809 funds tracked by Wall St. Rank held iShares MSCI EAFE Value ETF as of Q2 2023.

Based on Alpha DNA Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.